CXCR4 and prostate carcinoma: To determine whether activation of the CXCR4/CXCL12 axis stimulates proliferation of prostate cancer progenitors, PC3 and DU145 cells were treated with CXCL12 at 10 and 100 ng/mL for 5 days in serum-free epithelial growth medium.